DJIA 17,272.61 -144.24 -0.83%
NASDAQ 4,668.71 -14.70 -0.31%
S&P 500 2,007.95 -13.30 -0.66%
market minute promo

Amgen, Inc. (NASDAQ: AMGN)

153.99 -2.38 (-1.52%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $153.91 -1.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $155.55
Previous Close $156.37
Daily Range $151.53 - $156.87
52-Week Range $108.20 - $173.14
Market Cap $117.1B
P/E Ratio 17.97
Dividend (Yield) $3.16 (2.0%)
Ex-Dividend Date
Dividend Pay Date
02/10/15
03/06/15
Volume 2,684,651
Average Daily Volume 3,619,280
Current FY EPS $9.29

Sector

Healthcare

Industry

Drugs

Amgen, Inc. (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Amgen, Inc. Earnings: 1 Sentence That Tells You Everything You Need to Know

Amgen just reported its quarterly results and one sentence buried in its earnings report tells investors everything they need to know.

Protalex Aiming At Rheumatoid Arthritis Market With A Much Cheaper Price Tag

Regeneron Shows Biotech Investors Have Left Their Wildcatting Days

$CTIX - Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon

My Dividend Portfolio: 2014 Year In Review

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Earnings Update: Invest In Amgen For The Dividend And Pipeline

Amgen (AMGN) Stock Declines Today Despite Earnings Beat

Short Sellers Starting to Gang Up on Biotech

Credit Suisse Sees Solid Q4 For Amgen

Amgen (AMGN) Earnings Report: Q4 2014 Conference Call Transcript

See More AMGN News...

AMGN's Top Competitors

AMGN $153.99 (-1.52%)
Current stock: AMGN
GILD $105.02 (0.81%)
Current stock: GILD
CELG $120.49 (-0.31%)
Current stock: CELG
$0.00 (0.00%)
Current stock: